设计一种随机,双盲的非劣势性试验治疗的挑战:SD-ACNE试验
John S Barbieri1, Susan Ellenberg2, Elizabeth Grice3
1Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.
Clinical trials (London, England)
|July 27, 2024
概括
这项研究将螺旋和多西环林与女性治疗进行比较. 螺旋龙可能与多西环素一样有效,为抗生素提供替代品,并改善抗生素管理.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 微生物学 微生物学
背景情况:
- 抗生素耐药性是一个越来越令人担忧的问题,特别是对于的处方率很高.
- 口服抗生素是一种常见的治疗方法,但替代品未得到充分利用.
- Спиронолактон为提供一种荷尔蒙疗法选择,解决其病原性.
研究的目的:
- 评估螺旋龙在治疗女性方面是否与多西环素不逊色.
- 为了比较spironolactone和doxycycline在减少炎症性病变方面的有效性.
- 评估这些治疗对生活质量和皮肤微生物群的影响.
主要方法:
- 螺旋和多西环林治疗的试验 (SD-ACNE) 是一项有效性比较,非劣势性研究.
- 参与者被随机分配给接受16周的螺旋 (100毫克/天) 或多西环林甲酸盐 (100毫克/天).
- 主要结局是炎症病变数的绝对减少,其非劣势率为4个病变.
主要成果:
- 这项研究正在进行中,结果尚未公布.
- 关键的次要结果包括调查员全球评估的成功,生活质量的变化和微生物组分析.
- 该试验的目的是提供关于螺旋龙与多西环素的比较疗效和安全性的数据.
结论:
- 这项试验将为女性的治疗决策提供信息,可能减少抗生素的使用.
- 这些发现将有助于理解全身治疗对微生物群的影响.
- 这项研究涉及管理和抗生素管理的关键问题.
更多相关视频
相关概念视频
01:11Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
02:07Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
01:16Crossover Experiments
2.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.7K
01:13Randomized Experiments
6.8K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.8K
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K